INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

SANASana Biotechnology, Inc.

CIK 0001770121

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections3with evidence

SANA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
PD
Patel Dhavalkumar DhirajlalEVP, Chief Scientific Officer
SANASana Biotechnology, Inc.
Option exercise
M—
125.0K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Patel Dhavalkumar DhirajlalEVP, Chief Scientific Officer · Aug 27, 2026
  • ← Insider ofevidence
    Seitz MichelleDirector · Jun 5, 2026
20
PD
Patel Dhavalkumar DhirajlalEVP, Chief Scientific Officer
SANASana Biotechnology, Inc.
Tax withholding
F
$169K
41.2K sh
Aug 27, 2026
Aug 27, 2026
traded Aug 27, 2026
+0d
SEC FORM 4

Evidence

21
PD
Patel Dhavalkumar DhirajlalEVP, Chief Scientific Officer
SANASana Biotechnology, Inc.
Option exercise
M—
125.0K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC FORM 4

Evidence

9
SM
Seitz MichelleDirector
SANASana Biotechnology, Inc.
Grant or award
A—
90.0K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence